Vacuum Blood Collection Tube Market Expands with Advances in Diagnostic Efficiency

The global vacuum blood collection tube market size is calculated at USD 3.16 billion in 2025 and is forecasted to reach around USD 4.22 billion by 2034, accelerating at a CAGR of 3.27% from 2025 to 2034. The North America market size surpassed USD 1.10 billion in 2024 and is expanding at a CAGR of 3.42% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : 08 Jul 2025  |  Report Code : 6356  |  Category : Healthcare   |  Format : PDF / PPT / Excel

List of Contents

  • Last Updated : 08 Jul 2025
  • Report Code : 6356
  • Category : Healthcare

Vacuum Blood Collection Tube Market Size and Forecast 2025 to 2034

The global vacuum blood collection tube market size accounted for USD 3.06 billion in 2024 and is predicted to increase from USD 3.16 billion in 2025 to approximately USD 4.22 billion by 2034, expanding at a CAGR of 3.27% from 2025 to 2034. The vacuum blood collection tube market is growing due to rising demand for accurate diagnostics, increased prevalence of chronic diseases, and advancements in healthcare infrastructure.

Vacuum Blood Collection Tube Market Size 2025 to 2034

Vacuum Blood Collection Tube Market Key Takeaways 

  • In terms of revenue, the global vacuum blood collection tube market was valued at USD 3.06 billion in 2024.
  • It is projected to reach USD 4.22 billion by 2034.
  • The market is expected to grow at a CAGR of 3.27% from 2025 to 2034.
  • North America dominated the global vacuum blood collection tube market with the largest market share of 36% in 2024.
  • Asia Pacific is anticipated to witness the fastest growth during the forecast years.
  • By product type, the serum tubes segment captured the biggest market share of 32% in 2024.
  • By product type, the plasma separation tubes segment is anticipated to show considerable growth over the forecast period.
  • By material, the plastic segment contributed the largest market share of 88% share in 2024.
  • By material, the glass segment is anticipated to show notable growth over the forecast period.
  • By application, the routine chemistry segment generated the major market share of 28% in 2024.
  • By application, the infectious disease testing segment is anticipated to show considerable growth in the market over the forecast period.
  • By end user, the hospitals segment held the biggest market share of 41% in 2024.
  • By end user, the diagnostic laboratories segment is anticipated to show considerable growth over the forecast period.
  • By distribution channel, the direct tender segment accounted for biggest market share of 46% in 2024.
  • By distribution channel, the online sales segment is anticipated to show considerable growth over the forecast period.

How is AI Enhancing the Accuracy and Efficiency in Blood Collection?

Artificial Intelligence is revolutionizing blood medicine supply by enabling real-time tracking of blood samples using barcodes or smart labels. AI also aids in selecting the correct tube type and blood quantity for each test. In busy labs, AI streamlines tube handling, saving time and identifying unusual test results to alert staff. This early monitoring enhances patient management by ensuring reliable results, making vacuum blood collection faster, safer, and more productive, ultimately leading to better outcomes for patients and healthcare professionals. Furthermore, AI helps track blood collection volumes, flags potential errors in testing, and provides more accurate results, potentially leading to advancements in tube design, materials, and manufacturing, thereby enhancing diagnostic accuracy and safety.

U.S. Vacuum Blood Collection Tube Market Size and Growth 2025 to 2034

The U.S. vacuum blood collection tube market size was exhibited at USD 771.12 million in 2024 and is projected to be worth around USD 1,085.91 million by 2034, growing at a CAGR of 3.48% from 2025 to 2034.

U.S. Vacuum Blood Collection Tube Market Size 2025 to 2034

Why Did North America Lead the Vacuum Blood Collection Tube Market?

North America led the global market while holding a 36% in 2024. This is mainly due to the presence of leading manufacturers of medical devices, including vacuum blood collection tube. Major manufacturers and suppliers have established significant businesses in the region, streamlining distribution, innovation, and product availability. The increased prevalence of chronic diseases like diabetes, cardiovascular diseases, and cancer is driving the need for frequent blood testing, necessitating the development of effective and safe blood collection systems. Government support and funding for healthcare services, along with regulatory schemes, ensure the use of quality and compliant medical products in hospitals and labs.

The U.S. dominates the North American vacuum blood collection tube market. The increased prevalence of chronic diseases, which require regular diagnostic tests, has led to a rise in the use of vacuum blood collection tubes in hospitals, clinics, and labs. There is a strong focus on patient-centered care in the U.S., which futlrther boosts the adoption of new, non-invasive blood sample collection techniques.

Vacuum Blood Collection Tube Market Share, By Region, 2024 (%)

Why is Asia Pacific Witnessing the Fastest Growth in the Vacuum Blood Collection Tube Market?

Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The prevalence of chronic and lifestyle-related diseases is increasing in the region. An aging population in countries like China and India are leading to a rise in chronic disease prevalence, which are diagnosed and monitored through blood tests. The increasing prevalence of diabetes is driving the demand for glucose monitoring and, consequently, vacuum blood collection tubes. The rising need for effective, accurate, and safe blood collection devices in hospitals, clinics, and diagnostic labs further contributes to regional market growth.

China significantly contributes to the growth of the Asia Pacific vacuum blood collection tube market. Government efforts to improve healthcare infrastructure and primary diagnosis are increasing the demand for diagnostic equipment, including vacuum blood collection tubes. The Chinese government’s focus on improving diagnostics and population health is encouraging manufacturers to invest in this area.

What are the Major Factors Driving the Growth of the Europe Vacuum Blood Collection Tube Market?

The market within Europe is expected to grow at a notable rate. The growth of diagnostic labs and hospital facilities, along with the integration of automated laboratory systems, is boosting the need for effective blood collection solutions. This has led to the introduction of vacuum blood collection tubes as a crucial part of maintaining sample integrity and improving the reliability of diagnostic procedures. The trend toward preventive healthcare and early disease screening in Europe is also leading to more routine check-ups and screenings that rely heavily on blood testing.

The UK is a major player in the European market, largely due to the increase in cancer cases. The trend toward personalized medicine and precision oncology in the UK also increases the need for advanced blood collection technologies. Government projects and budgets allocated to developing cancer diagnostics and reducing waiting times further increase the use of vacuum blood collection tubes in the UK.

Market Overview

The vacuum blood collection tube market refers to the global industry involved in the production and distribution of sterile, vacuum-sealed tubes used to collect, transport, and store blood samples for diagnostic, therapeutic, and research purposes. These tubes are pre-evacuated to draw a specific volume of blood directly from a vein into the container during venipuncture. They are widely used in hospitals, diagnostic laboratories, outpatient centers, and blood banks for various tests, including hematology, biochemistry, serology, and molecular diagnostics. The market is driven by increased diagnostic testing, rising disease burden, technological advancements in blood collection devices, and the growing need for safe and efficient blood collection systems.

The vacuum blood collection tube market is experiencing significant growth, driven by the rising prevalence of chronic and infectious diseases, including diabetes and cardiovascular conditions. These diseases necessitate frequent blood tests for diagnosis and monitoring of patient health, thereby increasing the demand for safe and accurate blood collection methods. Furthermore, the global increase in blood transfusions and surgical procedures is also contributing to the market’s expansion.

What Factors Are Fueling the Growth of the Vacuum Blood Collection Tube Market?

  • Increasing Incidence of Chronic and Infectious Disease: The demand for screening tests is escalating due to the rise in diabetes, cardiovascular diseases, cancer, and infectious diseases like HIV, tuberculosis, hepatitis, and COVID-19. Vacuum tubes provide a precise, effective, and non-contaminating method for blood sampling, which is crucial for disease monitoring.
  • Development of Medical Facilities in Emerging Economies: The rapid expansion of hospitals, diagnostic labs, and blood banks is boosting the adoption of vacuum blood collection tubes. Increased healthcare spending and medical tourism are prompting both government and private sectors to invest in expanded testing facilities, making vacuum collection products essential for these new and improved healthcare settings.
  • Automation & Technological Developments: Innovations such as PET plastic tubes (safer and more durable than glass), color-coded caps, barcoding, pre-barcoded tubes, heparin coatings, and automated pressure vacuum systems are enhancing lab efficiency. These advancements improve sample integrity, compatibility with automation, reduce hemolysis and errors, and facilitate robotic lab workflows.

Market Scope

Report Coverage       Details
Market Size by 2034 USD 4.22 Billion
Market Size in 2025 USD 3.16 Billion
Market Size in 2024 USD 3.06 Billion
Market Growth Rate from 2025 to 2034 CAGR of 3.27%
Dominating Region North America
Fastest Growing Region Asia Pacific
Base Year 2024
Forecast Period 2025 to 2034
Segments Covered Product Type, Material, Application, End User, Distribution Channel, and Region
Regions Covered     North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics

Drivers

Strong Emphasis on Early Detection

With the increased burden of diseases like diabetes, heart problems, cancer, and autoimmune conditions, there is a strong emphasis on early disease detection. Moreover, the rise of infectious diseases like HIV, hepatitis, tuberculosis, and COVID-19 has increased the demand for precise and rapid diagnostic tests. Routine blood testing is crucial for assessing patient responses to treatment and disease progression. As more people require regular and reliable diagnostic testing, healthcare systems are adopting innovative blood collection strategies to ensure quality and reduce contamination risks. Government and healthcare initiatives promoting preventive checkups and screenings have further increased the demand for safe and effective blood sampling equipment.

Restraint

Supply Chain Issues

The major factor hindering the growth of the global vacuum blood collection tube market is the supply chain vulnerability of raw materials, particularly polyethylene. Polyethylene, a plastic used in manufacturing blood collection tubes, is closely linked to the global oil market. Fluctuations in crude oil prices impact the cost and supply of polyethylene, making production unpredictable. Material shortages can arise from geopolitical tensions, trade restrictions, transportation delays, or natural disasters, disrupting the supply chain. These factors force manufacturers to adjust prices frequently, destabilizing the industry and affecting operational efficiency.

Opportunity

Product Customization for Personalized Medicine

The rise of personalized medicine presents a significant opportunity in the global vacuum blood collection tube market. As healthcare shifts toward customized diagnostics and therapies, specialized blood collection procedures have become more important. Companies like Becton Dickinson are leading the way by developing blood collection tubes tailored for specific genetic testing or biomarker analysis. These innovations are crucial for detecting gene mutations and cancer markers, which are essential for targeted therapies.

Product Type Insights

Why Did the Serum Tubes Segment Dominate the Vaccum Blood Collection Tube in 2024?

The serum tubes segment dominated the market while holding the largest share in 2024. This is mainly due the widespread use of serum tubes in various biochemical and serological tests. These tubes are favored in clinical labs because they provide high-quality serum samples with minimal interference. The rise in chronic diseases like heart disease, diabetes, and cancer created the need for diagnostic procedures, thus increasing the demand for serum separator tubes (SSTs). Technological advancements have also improved their efficiency, sample integrity, and shelf life. The growth of personalized medicine is driving the need for more individualized diagnostic products, prompting manufacturers to develop SSTs tailored to specific regional needs in biomarker and genetic testing.

The plasma separation tubes segment is expected to grow at a significant CAGR over the forecast period. These tubes are designed to separate plasma from whole blood using a gel or additive barrier after centrifugation, allowing for quick and uncontaminated extraction. The growing need for accurate, efficient, and cost-effective blood analysis, especially in infectious disease testing, hormone tests, and drug level detection, is driving medical facilities to use plasma separation tubes. These tubes ensure high-quality samples and reduce the risk of hemolysis, simplifying lab work.

Material Insights

How Does the Plastic Segment Dominate the Market in 2024?

The plastic segment dominated the vaccum blood collection tube market with a 88% revenue share in 2024 and is expected to sustain its position during the forecast period. This is because of the increased use of polyethylene terephthalate (PET) as the material of choice in the manufacturing process. PET tubes are strong, lightweight, break-resistant, and safer than glass. Their high chemical resistance ensures that blood samples remain stable and uncontaminated during transport and storage, crucial for accurate testing. The increasing automation in labs also favors PET, as these plastic tubes are easily handled by high-throughput systems and robots.

Vacuum Blood Collection Tube Market Share, By Material, 2024 (%)

The glass segment is expected to grow at a notable rate in the upcoming period. Glass is ideal for sensitive assays needing a stable environment because it doesn’t interact with blood or additives. Its resistance to gas permeability and clarity make it useful in biochemical and serological tests. Manufacturers are also working on making glass tubes stronger and less fragile.

Application Insights

What Made Routine Chemistry the Dominant Segment in the Market in 2024?

The routine chemistry segment dominated the vaccum blood collection tube market, capturing a 28% share in 2024. This is mainly due to the increased burden of chronic diseases like hypertension, diabetes, heart disease, and cancers. These diseases require routine blood testing to get insights into diseases progression and manage conditions. The growing awareness of preventive care and more routine checkups are boosting the demand for blood testing services globally. Developing countries are also expanding their healthcare infrastructure, making diagnostic services more accessible.

The infectious disease testing segment is expected to grow at a significant CAGR over the forecast period. Vacuum blood collection tubes are crucial in diagnosing viral infections such as HIV, hepatitis, tuberculosis, and COVID-19. The rising concern about infection control and the demand for early detection globally are driving the need for these diagnostic methods, especially in high-risk areas. As governments and health institutions invest in improving diagnostic capacity and lab networks, particularly in low and middle-income economies, the use of these tubes in infectious disease testing is expected to increase.

End-user Insights

Why Did the Hospitals Segment Lead the Market?

The hospitals segment continues to dominate the vaccum blood collection tube market. Hospitals, serving as major care points, handle numerous patients daily and conduct many diagnostic analyses, including routine blood tests, emergency testing, and screenings. The high clinical standards in hospitals encourage the use of high-quality collection systems. As healthcare infrastructure improves globally and chronic and infectious diseases increase, hospitals are performing more routine and preventative analyses.

The diagnostic laboratories segment is expected to grow at the highest CAGR in the upcoming period. Diagnostic laboratories play a crucial role in disease diagnosis, treatment monitoring, and health screening. As lab tasks vary, from simple hematology to complex genetic diagnostics, the need for specialized collection tubes increases. Accuracy and efficiency are priorities in diagnostic labs, making vacuum tubes essential because they fit into automated systems and preserve sample integrity. The increased patient footfall in these laboratories further contributes to segmental growth. The growth of private lab chains, the demand for healthcare prevention education, and the rise in home collection services ensure the long-term growth of the segment. 

Distribution Channel Insights

What Made Direct Tender the Dominant Segment in the Market in 2024?

The direct tender segment captured a revenue share of 46% in 2024. This is mainly due to the increased need for immediate delivery of products. Direct tenders ensure timely procurement, reduce administrative costs, and enable cost-effective bulk purchases at negotiated rates. Healthcare providers, especially in centralized healthcare regions, find the efficiency of direct tenders appealing. This procurement system remains a primary mode for the mass supply and distribution of vacuum blood collection tubes.

The online sales segment is expected to grow at a significant CAGR over the forecast period. The increasing digitalization of purchase activities, along with the ease of use on e-commerce websites, attracts healthcare facilities, diagnostic labs, and practitioners to online purchasing of vacuum blood collection tubes. Online platforms improve accessibility to a wide range of products. These platforms offer competitive pricing and doorstep delivery services, encouraging reapeat purchases. Manufacturers are also focusing on expanding their online presence to reach buyers directly and offer tailored products, supporting segmental growth.

Vacuum Blood Collection Tube Market Companies

Vacuum Blood Collection Tube Market Companies
  • Becton, Dickinson and Company (BD)
  • Greiner Bio-One GmbH
  • Terumo Corporation
  • SARSTEDT AG & Co. KG
  • FL Medical
  • Improve Medical Instruments Co., Ltd.
  • Narang Medical Limited
  • CML Biotech Pvt. Ltd.
  • Medtronic plc
  • Labtech Disposables
  • Biosigma S.p.A.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Hebei Xinle Sci & Tech Co., Ltd.
  • Sekisui Medical Co., Ltd.
  • Zhejiang Gongdong Medical Technology Co., Ltd.
  • Hindustan Syringes & Medical Devices Ltd.
  • Kabe Labortechnik GmbH
  • Nipro Corporation
  • Vital Diagnostics
  • Jiangsu Kangjie Medical Devices Co., Ltd.

Recent Developments

  • In April 2024, Streck, Inc. announced the launch of Protein Plus BCT, which is a direct whole blood draw collection tube that can stabilize the draw-time concentration of plasma proteins while in ambient temperature storage.
  • In April 2024, Becton, Dickinson and Company released the BD Vacutainer UltraTouch Push Button Blood Collection Set in India, which uses BD RightGauge technology to accommodate a thinner needle to collect blood while using BD PentaPoint technology to significantly lessen insertion pain experienced by patient customers. 
  • In February 2024, Cangzhou Fukang Medical Supplies Co., Ltd. introduced a potentially innovative development in their new blood collection tube. The innovation consists of a new blood collection tube that will change blood collection and storage for their professional customers.

(Source: https://www.captodayonline.com)
(Source: https://www.bd.com)
(Source: https://www.cangzhoufukang.com)

Segments Covered in the Report

By Product Type

  • Serum Tubes
  • Plasma Separation Tubes
  • Heparin Tubes
  • EDTA Tubes
  • Glucose Tubes
  • ESR Tubes
  • Others (Thrombin Tubes, Trace Element Tubes, etc.)

By Material

  • Plastic
  • Glass

By Application

  • Routine Chemistry
  • Blood Sugar Testing
  • Coagulation Testing
  • Lipid Profile
  • Infectious Disease Testing
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Ambulatory Surgical Centers
  • Others (Academic Institutes, Research Labs)

By Distribution Channel

  • Direct Tender
  • Retail Sales
  • Online Sales
  • Distributors

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com

Frequently Asked Questions

The global vacuum blood collection tube market is expected to increase from USD 3.06 billion in 2024 to USD 4.22 billion by 2034.

The vacuum blood collection tube market is expected to grow at a compound annual growth rate (CAGR) of around 3.27% from 2025 to 2034.

The major players in the vacuum blood collection tube market include Becton, Dickinson and Company (BD), Greiner Bio-One GmbH, Terumo Corporation, SARSTEDT AG & Co. KG, FL Medical, Improve Medical Instruments Co., Ltd., Narang Medical Limited, CML Biotech Pvt. Ltd., Medtronic plc, Labtech Disposables, Biosigma S.p.A., Guangzhou Wondfo Biotech Co., Ltd., Hebei Xinle Sci & Tech Co., Ltd., Sekisui Medical Co., Ltd., Zhejiang Gongdong Medical Technology Co., Ltd., Hindustan Syringes & Medical Devices Ltd., Kabe Labortechnik GmbH, Nipro Corporation, Vital Diagnostics, and Jiangsu Kangjie Medical Devices Co., Ltd.

The driving factors of the vacuum blood collection tube market are the demand for screening tests is escalating due to the rise in diabetes, cardiovascular diseases, cancer, and infectious diseases like HIV, tuberculosis, hepatitis, and COVID-19.

North America region will lead the global vacuum blood collection tube market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey, one of our esteemed authors, plays a crucial role in shaping the high-quality content that defines our research reports. Deepa holds a Master's in Pharmacy with a specialization in Pharmaceutical Quality Assurance, equipping her with an in-depth understanding of the healthcare industry's regulatory, quality, and operational nuances. With 2+ years of experience in market research, Deepa has made

Learn more about Deepa Pandey

With over 14 years of experience, Aditi is the powerhouse responsible for reviewing every piece of data and content that passes through our research pipeline. She is not just an expert—she’s the linchpin that ensures the accuracy, relevance, and clarity of the insights we deliver. Aditi’s broad expertise spans multiple sectors, with a keen focus on ICT, automotive, and various other cross-domain industries.

Learn more about Aditi Shivarkar

Related Reports